- Home
- PWR vs BMY Comparison
PWR vs BMY Comparison
Compare PWR & BMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PWR | BMY |
|---|---|---|
| Founded | 1997 | 1887 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Engineering & Construction | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 99.6B | 113.5B |
| IPO Year | 1997 | 2006 |
Fundamental Metrics
Financial Performance| Metric | PWR | BMY |
|---|---|---|
| Price | $548.03 | $61.69 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 31 | 28 |
| Target Price | ★ $766.01 | $65.63 |
| AVG Volume (30 Days) | 954.5K | ★ 11.8M |
| Earning Date | 10-29-2026 | 10-29-2026 |
| Dividend Yield | 0.08% | ★ 4.00% |
| EPS Growth | 12.77 | ★ 178.46 |
| EPS | ★ 4.41 | 2.93 |
| Revenue | $28,479,697,000.00 | ★ $48,194,000,000.00 |
| Revenue This Year | $38.92 | $3.50 |
| Revenue Next Year | $15.75 | N/A |
| P/E Ratio | $125.30 | ★ $21.49 |
| Revenue Growth | ★ 20.31 | N/A |
| 52 Week Low | $408.36 | $42.52 |
| 52 Week High | $788.75 | $68.64 |
Technical Indicators
Market Signals| Indicator | PWR | BMY |
|---|---|---|
| Relative Strength Index (RSI) | 28.27 | 51.82 |
| Support Level | $536.05 | $59.91 |
| Resistance Level | $578.85 | $62.77 |
| Average True Range (ATR) | 28.22 | 1.81 |
| MACD | -15.42 | 0.50 |
| Stochastic Oscillator | 10.65 | 75.07 |
Price Performance
Historical ComparisonAbout PWR Quanta Services Inc.
Quanta Services is a leading specialty contractor serving customers across the utility, telecom, oil and gas, and renewable energy markets. The company operates through two segments: electric and underground utility. Through a combination of organic growth and a disciplined acquisition strategy, Quanta has grown into the largest provider of electric transmission and distribution contracting services in the US.
About BMY Bristol-Myers Squibb Company
Bristol Myers Squibb discovers, develops, and markets drugs for various therapeutic areas, such as cardiovascular, cancer, and immune disorders. A key focus for Bristol is immuno-oncology, where the firm is a leader in drug development. Bristol derives close to 70% of total sales from the US, showing a higher dependence on the US market than most of its peer group.